General Information of Drug (ID: DMQFPI1)

Drug Name
mRNA-3927 Drug Info
Indication
Disease Entry ICD 11 Status REF
Propionic acidemia 5C50.E0 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMQFPI1

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Propionyl-CoA carboxylase alpha chain, mitochondrial messenger RNA (PCCA mRNA) TT1JDE3 PCCA_HUMAN Not Available [2]
Propionyl-CoA carboxylase beta chain, mitochondrial messenger RNA (PCCB mRNA) TT5LURU PCCB_HUMAN Not Available [2]

References

1 ClinicalTrials.gov (NCT05130437) A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study. U.S.National Institutes of Health.
2 Translational Pharmacokinetic/Pharmacodynamic Model for mRNA-3927, an Investigational Therapeutic for the Treatment of Propionic Acidemia. Nucleic Acid Ther. 2023 Apr;33(2):141-147.